Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
36.77 +0.21 (+0.57%) 12:50 ET [NASDAQ]
36.72 x 22 36.84 x 8
Realtime by (Cboe BZX)
36.72 x 22 36.84 x 8
Realtime 36.39 -0.17 (-0.46%) 07:33 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
36.59
Day High
37.76
Open 37.13
Previous Close 36.56 36.56
Volume 385,677 385,677
Avg Vol 1,896,371 1,896,371
Stochastic %K 90.46% 90.46%
Weighted Alpha -9.17 -9.17
5-Day Change +0.38 (+1.04%) +0.38 (+1.04%)
52-Week Range 29.17 - 62.40 29.17 - 62.40
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,796,980
  • Shares Outstanding, K 185,913
  • Annual Sales, $ 0 K
  • Annual Income, $ -600,090 K
  • EBIT $ -690 M
  • EBITDA $ -722 M
  • 60-Month Beta 1.37
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.73

Options Overview Details

View History
  • Implied Volatility 57.93% ( -3.59%)
  • Historical Volatility 56.87%
  • IV Percentile 50%
  • IV Rank 15.97%
  • IV High 147.63% on 07/11/24
  • IV Low 40.89% on 01/14/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 283
  • Put/Call OI Ratio 1.37
  • Today's Open Interest 15,384
  • Open Int (30-Day) 13,283

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.10
  • Number of Estimates 7
  • High Estimate -0.89
  • Low Estimate -1.23
  • Prior Year -0.70
  • Growth Rate Est. (year over year) -57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.17 +26.33%
on 04/07/25
Period Open: 38.11
39.59 -6.92%
on 03/24/25
-1.26 (-3.31%)
since 03/21/25
3-Month
29.17 +26.33%
on 04/07/25
Period Open: 40.92
44.68 -17.52%
on 02/05/25
-4.07 (-9.95%)
since 01/22/25
52-Week
29.17 +26.33%
on 04/07/25
Period Open: 36.43
62.40 -40.95%
on 11/11/24
+0.42 (+1.15%)
since 04/22/24

Most Recent Stories

More News
Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting

RVMD : 36.77 (+0.57%)
Revolution Medicines to Participate in April 2025 Investor Conferences

RVMD : 36.77 (+0.57%)
Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate Progress

RVMD : 36.77 (+0.57%)
Revolution Medicines to Participate in March 2025 Investor Conferences

RVMD : 36.77 (+0.57%)
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025

RVMD : 36.77 (+0.57%)
Revolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech Conference

RVMD : 36.77 (+0.57%)
Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference

RVMD : 36.77 (+0.57%)
Revolution Medicines Closes $862.5 Million Underwritten Public Offering of Common Stock

Revolution Medicines closed a public offering of 16.6 million shares, raising $862.5 million for RAS-addicted cancer therapies.Quiver AI SummaryRevolution Medicines, Inc. has successfully completed its...

RVMD : 36.77 (+0.57%)
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares

RVMD : 36.77 (+0.57%)
Revolution Medicines Prices Public Offering of Common Stock and Pre-Funded Warrants, Aiming for $750 Million in Proceeds

Revolution Medicines announced a public offering of 14.1 million shares priced at $46 each, aiming for $750 million proceeds.Quiver AI SummaryRevolution Medicines, Inc., a clinical-stage oncology company...

RVMD : 36.77 (+0.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 39.51
2nd Resistance Point 38.70
1st Resistance Point 37.63
Last Price 36.77
1st Support Level 35.75
2nd Support Level 34.94
3rd Support Level 33.87

See More

52-Week High 62.40
Fibonacci 61.8% 49.71
Fibonacci 50% 45.78
Fibonacci 38.2% 41.86
Last Price 36.77
52-Week Low 29.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro